Stem Cell Breakthrough Is Like 'Turning Lead Into Gold'
By Brandon Keim,
Wired
| 11. 21. 2007
[Quotes CGS's Marcy Darnovsky]
In an unprecedented feat of biological alchemy, researchers have turned human skin cells into stem cells that hold the same medical promise as controversial embryonic stem cells.
Two teams of researchers -- one led by Kyoto University's Shinya Yamanaka, the other by the University of Wisconsin's Junying Yu -- used a virus to add four new genes to skin cells. Thus transformed, the reprogrammed cells became capable of changing into nearly any cell type in the human body. Embryonic stem cells also have this ability, and may someday be used to cure degenerative diseases, grow new organs and even replace limbs.
"It's a new era for stem cells," said Robert Lanza, chief science officer of Advanced Cell Technologies, a cloning company in California. "It's the holy grail. It's like turning lead into gold."
Scientists have hailed embryonic stem cells as one of the most promising research fields in medicine, saying they could lead to myriad therapies. But currently, many stem cells are derived from embryos, which is a lightning rod issue that crosses political and religious lines...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...